Anti-basement membrane antibody mediated disease: Revision of 32 cases and follow-up at one year of the diagnosis;Enfermedad por Ac anti-MBG: Revisión de 32 casos y seguimiento al año del diagnóstico

Nefrologia

Volumn 23, Issue 5, 2003, Pages 415-422

  Saurina, A ^a,b   Arrizabalaga, P ^b   Rodriguez R ^b   Poveda, R ^c   Valles M ^d   Pou, M ^a   Mirapeix, E ^b  

^a Servicios Nefrologia Hosp Terrassa   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

^c HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^d HOSPITAL JOSEP TRUETA   (Spain)

Author keywords

Anti basement membrane antibody mediated disease; Cell mediated immunity; Goodpasture's syndrome

Indexed keywords

BASEMENT MEMBRANE ANTIBODY; CORTIC; CORTICOSTEROID; CYCLOPHOSPHAMIDE; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; ANTIBODY; ANTIGLOMERULAR BASEMENT MEMBRANE ANTIBODY;

ADULT; AGED; ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; BASEMENT MEMBRANE ANTIBODY MEDIATED DISEASE; CELLULAR IMMUNITY; CLINICAL ARTICLE; CLINICAL FEATURE; CREATININE BLOOD LEVEL; DIAGNOSTIC TEST; FEMALE; FOLLOW UP; GLOMERULONEPHRITIS; HUMAN; HUMORAL IMMUNITY; IMMUNOCOMPETENT CELL; IMMUNOHISTOCHEMISTRY; KIDNEY INJURY; KIDNEY TRANSPLANTATION; LEUKOCYTE; LUNG HEMORRHAGE; MALE; MORBIDITY; MORTALITY; PROGNOSIS; RETROSPECTIVE STUDY; REVIEW; SURVIVAL; TIME SERIES ANALYSIS; ADOLESCENT; ARTICLE; BASEMENT MEMBRANE; BLOOD; GLOMERULUS; IMMUNOLOGY; MIDDLE AGED; RENAL REPLACEMENT THERAPY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-GLOMERULAR BASEMENT MEMBRANE DISEASE; ANTIBODIES; BASEMENT MEMBRANE; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNITY, CELLULAR; KIDNEY GLOMERULUS; MALE; MIDDLE AGED; RENAL REPLACEMENT THERAPY; RETROSPECTIVE STUDIES;

EID: 1542441386     PISSN: 02116995     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (47)

1. Kalluri R, Wilson CB, Webwe M, Gunvar S, Chonko AM, Neilson EG, Hudson BG: Identification of the α3 chain of type IV colagen as the common autoantigen in antibasement membrane disease and Goodpasture syndrome. J Am Soc Nephrol 6: 1178-1185, 1995.
2. Goodpasture EW: The significance of certain pulmonary lesions in relation to the etiology of influenza. Am J Med 158: 863-870, 1919.
3. Staton MC, Tange JD: Goodpasture's syndrome: pulmonary hemorrhage associated with glomerulonephritis. Aust Ann Med 7: 132-144, 1958.
4. Lerner RA, Glassock RJ, Dixon FJ: The role of anti-glomerular basement membrane antibody in the pathogenesis of human glomerulonephritis. J Exp Med 126: 989-1004, 1967.
5. Wieslander J, Barr JF, Butkowski RJ, Edwards SJ, Bygren P, Heinegard D, Hudson BG: Goodpasture antigen of the glomerular basement membrane: localization to noncollagenous regions of type IV collagen. Proc Natl Acad Sci USA 81: 3838-3842, 1984.
6. Weber M, Pullong O, Kohler H: Distribution of Goodpasture antigens within various human basement membranes. Nephrol Dial Transplant 5: 87-93, 1990.
7. Couser WG: Rapidly progresive glomerulonephritis: classification, pathogenetic mechanisms, and therapy. Am J Kidney Dis 11: 449-464, 1988.
8. Wilson CB: Goodpasture syndrome and other anti-basement membrane antibody diseases. En: Robert R. Rich: Clinical Immunology. Principles and Practice. Mosby pp. 1185-1191, 1996.
9. Arrizabalaga P, Darnell A, Mirapeix E, Torras A, Revert L: Análisis de la infiltración intraglomerular de leucocitos y actividad de la lesión glomerular en las glomerulonefritis proliferativas. Nefrología 15: 34-41, 1995.
10. Engel P, Serra C, Acevedo G, Vilella R, Gallart T: Involvement of CD18 and CD54 in the mixed lymphocyte reaction to leukemic CD5+ BH lymphocytes. Immunology 11: 21-31, 1992.
11. Bernstein ID, Self S: Joint report of the myeloid section of the Second International Workshop on human leucocyte differentiation antigens. En: Reinherz EL, Haynes BF, Nadler LM, Bernstein ID (eds.). Leucocyte Typing II. New York: Springer-Verlag 1-25, 1986.
12. Teague CA, Doak PB, Simpson IA, Rainer SP, Herdson PB: Goodpasture's syndrome: an analysis of 29 cases. Kidney Int 13: 492-504, 1978.
13. Savage CO, Pusey CD, Bowman C, Rees AJ, Lockwood CM: Antiglomerular basement membrane antibody meadiated disease in the British Isles 1980-4. Br Med J 292: 301-304, 1986.
14. Herody M, Bobrie G, Gourin C, Grünffeld JP, Noel LH: Anti-GBM disease: predictive value of clinical, histological and serological data. Clin Nephrol 40, 5: 249-255, 1993.
15. Merkel F, Pulling O, Marx M, Netzer KO, Weber M: Course and prognosis of anti-basement membrane antibody (anti-BM-Ab)- mediated disease: report of 35 cases. Nephrol Dial Transplant 9: 372-376, 1994.
16. Kelly PT, Haponik EF: Goodpasture syndrome: molecular and clinical advances. Medicine 73 (4): 171-185, 1994.
17. Conlon PJ, Walshe JJ, Daly C, Carmody M, Keogh B, Donohoe J, O'Neill S: Antiglomerular basement membrane disease: the long-term pulmonary outcome. Am J Kidney Dis 233 (6): 794-796, 1994.
18. Rivera F, López-Gómez JM, Pérez-García R: Frequency of renal pathology in Spain 1994-1999. Nephrol Dial Transplant 17: 1594-1602, 2002.
19. Wilson CB, Dixon FJ: Anti-glomerular basement membrane antibody-induced glomerulonephritis. Kidney Int 3: 74-89, 1973.
20. Rees AJ, Lockwood CM: Antiglomerular basement membrane antibody-mediated nephritis. En: Schrier RW, Gottschalk CW (eds.). Diseases of the kidney. Boston: Little, Brown 2091-2126, 1988.
21. Turner AN, Rees AJ: Anti-glomerular basement membrane disease. En: Pusey CD, Rees AJ: Rapidly progressive glomerulonephritis. Oxford University Press, pp. 108-124, 1997.
22. Churchill DN, Fine A, Gault MH: Association between hydrocarbon exposure and glomerulonephritis. An Appraisal of the evidence. Nephron 33: 169-172, 1983.
23. Ravnskov U, Lundstrom S, Norden A: Hydrocarbon exposure in glomerulonephritis: evidence from patients' occupations. Lancet 2: 1214-1216, 1983.
24. Daniell WE, Rosenstock L, Couser WG: Occupational solvent exposure and glomerulonephritis: a case report and review of the literature. JAMA 259 (15): 2280-2283, 1988.
25. 2 virus infection. Ann Intern Med 76: 91-94, 1972.
26. Sadjadi SA, Seeling MS, Berger AR, Milstoc M: Rapidly progressive glomerulonephritis in a patients with rheumatoid arthritis during treatment with high dosage D-penicillamine. Am J Nephrol 5: 212-216, 1985.
27. Meyrier A, Simon P, Mignon F, Striker L, Ramée MP: Rapidly progressive («crecentic») glomerulonephritis and monoclonal gammapathies. Nephron 38: 156-162, 1984.
28. Kebler R, Kithier K, McDonald FD, Cadnapaphornchai P: Rapidly progressive glomerulonephritis and monoclonal gammopathy. Am J Med 78: 133-138, 1985.
29. Pasternack A, Tornroth T, Linder E: Evidence of both anti-GBM and immune complex mediated pathogenesis in the initial phase of Goodpasture's syndrome. Clin Nephrol 9: 77-85, 1978.
30. Serra A, Cameron JS, Turner DR, Hartley B, Ogg CS, Neild GH, Williams DG, Taube D, Brown CB, Hicks JA: Vasculitis afecting the kidney: presentation, histopathology ad long-term outcome. Q J Med 210: 181-207, 1984.
31. Petzel RA, Brown DC, Staley NA, McMillan JJ, Sibley RK, Kjellstrand CM: Crescentic glomerulonephritis and renal failure associated with malignant lymphoma. Am J Clin Pathol 71: 728-732, 1979.
32. Biava CG, Gonwa TA, Naughton JL, Hopper JJr: Crescentic glomerulonephritis associated with nonrenal malignancies. Am J Nephrol 4: 208-214, 1984.
33. Rees AJ, Peters DK, Amos N, Welsh KI, Batchelor JR: The influence of HLA-linked genes on the severity of anti-GBM antibody-mediated nephritis. Kidney Int 26: 444-450, 1984.
34. Muller GA, Gebhardt M, Kompf Baldwin WM, Ziegenhagen D, Bohle A: Assoaciation between rapidly progressive glomerulonephritis and the properdin factor BfF and different HLA-D region products. Kidney Int 25: 115-118, 1984.
35. Donaghy M, Rees AJ: Cigarette smoking and lung hemorrhage in glomerulonephritis caused by autoantibodies to glomerular bassement membrane. Lancet 2: 1390-1392, 1983.
36. Bosch X, Mirapeix E, Font J, Borrellas X, Rodríguez R, López-Soto A, Ingelmo M, Revert I: Prognostic implication of anti-neutrophil cytoplasmic autoantibodies with myeloperoxidase specificity in anti-glomerular basement membrane disease. Clin Npehrol 36 (3): 107-113, 1991.
37. Saurina A, Ara J, Mirapeix E, Coll E, Vera M, Darnell A: Enfermedad por anticuerpos anti-membrana basal ¿una nueva enfermedad causante de fiebre de origen desconocido? Nefrología XX (1): 79-82, 2000.
38. Li HL, Hancock WW, Dowling JP, Atkins RC: Activated intraglomerular mononuclear cells in crescentic glomerulonephritis. Kidney Int 39: 793-798, 1991.
39. Arrizabalaga P, Sans A, Torras A, Darnell A, Revert L: Monoclonal antibody analysis of crescentic membranous glomerulonephropathy. Am J Nephrol 18: 77-82, 1998.
40. Reinhrz EL, Acuto O, Fabbi N, Bensussan A, Milanese C, Royer HD, Mener SC, Schlossman SF: Clonotypic surface structure on human T lymphocytes: functional and biochemical analysis of the antigen receptor complex. Immunol Rev 81: 95-129, 1984.
41. Tipping PG, Neale TJ, Holdsworth SR: T lymphocyte in antibody-induced experimental glomerulonephritis. Kidney Int 27: 530-537, 1985.
42. Schulz H, Karau A, Filsinger S: Tubular epithelial cells as accessory cells for superantigen-induced T cell activation. Exp Nephrol 6: 67-73, 1998.
43. Adler S, Brady HR: Cell adhesion molecules and the glomerulopathies. Am J Med 107: 371-386, 1999.
44. Benoit FL, Rulon DB, Theil GB, Doolan PD, Watten RH: Goodpasture's syndrome. A clinicopathologic entity. Am J Med 37: 424-444, 1964.
45. Bygren P, Freiburghaus C, Lindholm T, Simonsen O, Thysell H, Wieslander J: Goodpasture's syndrome treated with staphilococcal protein A immunoadsorption. Lancet 2: 1295-1296, 1985.
46. Moreso F, Poveda R, Gil-Vernet S, Carreras L, García-Osuna R, Griñó JM, Alsina A: Inmunoadsorción terapéutica en la enfermedad de Goodpasture. Med Clin (Barc) 105: 59-61, 1995.
47. Laczika K, Knapp S, Derfler K, Soleiman A, Hörl W, Druml W: Immunoadsorption in Goodpasture's syndrome. Am J Kidney Dis 36 (2): 392-395, 2000.